BI to pay $13.5 million for misleading marketing; ICER: CAR-T therapies more cost-effective than chemotherapy; FDA approves Roche’s breast cancer combo therapy
Five things for pharma marketers to know: Thursday, December 14, 2017
Pfizer develops Minecraft version for kids with hemophilia; Lilly to resubmit baricitinib to the FDA; pricing expert says Novartis CAR-T value contract is ‘progress’
Five things for pharma marketers to know: Monday, July 24, 2017
CVS will buy institutional pharmacy Omnicare in a $12.7-billion deal; ProPublica says the FDA and GlaxoSmithKline failed to protect patients from misusing Advair; Regeneron and Sanofi expect to file RA drug sarilumab with the FDA in the fourth quarter of this year
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix